Posttreatment Effect of MGMT Methylation Level on Glioblastoma Survival
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Posttreatment Effect of MGMT Methylation Level on Glioblastoma Survival
Authors
Keywords
-
Journal
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-05-06
DOI
10.1093/jnen/nlz032
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival data
- (2019) Wei Yang et al. Science Translational Medicine
- MGMT pyrosequencing-based cut-off methylation level and clinical outcome in patients with glioblastoma multiforme
- (2018) Lorena Gurrieri et al. Future Oncology
- The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female Power
- (2018) Enrico Franceschi et al. World Neurosurgery
- The prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials
- (2017) Maryam Moradi Binabaj et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Defining optimal cutoff value of MGMT promoter methylation by ROC analysis for clinical setting in glioblastoma patients
- (2017) Guoqiang Yuan et al. JOURNAL OF NEURO-ONCOLOGY
- European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
- (2017) Michael Weller et al. LANCET ONCOLOGY
- Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma
- (2017) James R. Perry et al. NEW ENGLAND JOURNAL OF MEDICINE
- Defining the cutoff value of MGMT gene promoter methylation and its predictive capacity in glioblastoma
- (2016) Giovanni Brigliadori et al. JOURNAL OF NEURO-ONCOLOGY
- Expression and prognostic value of the WEE1 kinase in gliomas
- (2016) Darija Music et al. JOURNAL OF NEURO-ONCOLOGY
- Association of the Extent of Resection With Survival in Glioblastoma
- (2016) Timothy J. Brown et al. JAMA Oncology
- The Prognostic Value of Pyrosequencing-Detected MGMT Promoter Hypermethylation in Newly Diagnosed Patients with Glioblastoma
- (2015) Veronica Villani et al. DISEASE MARKERS
- Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review)
- (2015) GIULIO CABRINI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- High levels of c-Met is associated with poor prognosis in glioblastoma
- (2015) Stine Asferg Petterson et al. JOURNAL OF NEURO-ONCOLOGY
- IDH mutation and MGMT promoter methylation in glioblastoma: results of a prospective registry
- (2015) Pei Yang et al. Oncotarget
- High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) R. Stupp et al. ANNALS OF ONCOLOGY
- Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients
- (2014) Véronique Quillien et al. JOURNAL OF NEURO-ONCOLOGY
- MGMT testing—the challenges for biomarker-based glioma treatment
- (2014) Wolfgang Wick et al. Nature Reviews Neurology
- Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma
- (2014) Anna Sophie Berghoff et al. NEURO-ONCOLOGY
- MGMT Promoter Methylation Correlates with an Overall Survival Benefit in Chinese High-Grade Glioblastoma Patients Treated with Radiotherapy and Alkylating Agent-Based Chemotherapy: A Single-Institution Study
- (2014) Dong Shen et al. PLoS One
- A population-based study of low-grade gliomas and mutated isocitrate dehydrogenase 1 (IDH1)
- (2013) Rikke H. Dahlrot et al. JOURNAL OF NEURO-ONCOLOGY
- Prognostic value of Musashi-1 in gliomas
- (2013) Rikke H. Dahlrot et al. JOURNAL OF NEURO-ONCOLOGY
- Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome
- (2013) Shadi Lalezari et al. NEURO-ONCOLOGY
- MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status
- (2012) Pierre Bady et al. ACTA NEUROPATHOLOGICA
- MGMT testing for glioma in clinical laboratories: discordance with methylation analyses prevents the implementation of routine immunohistochemistry
- (2012) Sofia Mason et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR
- (2012) Annette Håvik et al. Journal of Translational Medicine
- Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
- (2012) Annika Malmström et al. LANCET ONCOLOGY
- Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
- (2012) Wolfgang Wick et al. LANCET ONCOLOGY
- Prognostic Value of Three Different Methods of MGMT Promoter Methylation Analysis in a Prospective Trial on Newly Diagnosed Glioblastoma
- (2012) Arne Christians et al. PLoS One
- A distinct region of the MGMT CpG island critical for transcriptional regulation is preferentially methylated in glioblastoma cells and xenografts
- (2011) Deborah S. Malley et al. ACTA NEUROPATHOLOGICA
- Predictive impact of MGMT promoter methylation in glioblastoma of the elderly
- (2011) Guido Reifenberger et al. INTERNATIONAL JOURNAL OF CANCER
- MGMT CpG island is invariably methylated in adult astrocytic and oligodendroglial tumors with IDH1 or IDH2 mutations
- (2011) Shani Mulholland et al. INTERNATIONAL JOURNAL OF CANCER
- Comprehensive Analysis of MGMT Promoter Methylation: Correlation with MGMT Expression and Clinical Response in GBM
- (2011) Nameeta Shah et al. PLoS One
- A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomised trial
- (2010) Thomas Strøm et al. LANCET
- Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy
- (2009) J Dunn et al. BRITISH JOURNAL OF CANCER
- Assessing the Performance of Prediction Models
- (2009) Ewout W. Steyerberg et al. EPIDEMIOLOGY
- Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods
- (2009) Lucie Karayan-Tapon et al. JOURNAL OF NEURO-ONCOLOGY
- Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas
- (2009) Sibille Everhard et al. NEURO-ONCOLOGY
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now